Human sexuality

Sexual and Reproductive Heath, Rights and Justice Organizations Applaud Introduction of Legislations to Improve the Health and Well-Being of Young People

Retrieved on: 
Tuesday, May 18, 2021
Midwifery, Sexuality and society, Articles, Prevention of HIV/AIDS, Human sexuality, Harm reduction, Sex education, Reproductive health, Health, Comprehensive sex education, Reproductive justice

Together, these measures will help empower young people to make their own decisions about their bodies and lives.\n"All young people no matter who they are or where they live deserve high-quality, medically-accurate and inclusive sex education.

Key Points: 
  • Together, these measures will help empower young people to make their own decisions about their bodies and lives.\n"All young people no matter who they are or where they live deserve high-quality, medically-accurate and inclusive sex education.
  • "High-quality sex education can have an immense impact on a young person\'s life, and we must continue to break down the barriers for young people to access this information.
  • "\nThe introduction of this legislation coincides with Sex Ed For All Month , a national effort led by a coalition of sexual and reproductive health, rights and justice organizations committed to ensuring equitable and accessible sex education for all young people.
  • Throughout May, the coalition pledges to ensure all young people have equitable access to the sex education and sexual health care they deserve.

Bombardier Announces Closing of Placement of 7.45% Notes Due 2034 and Announces Amendment and Extension of Certain Consent Solicitations

Retrieved on: 
Tuesday, May 18, 2021
Articles, Sexual ethics, Autonomy, Ethics, Human sexuality, Rape, Sexual consent, Tort law, Consent

Following this private placement, the aggregate principal amount outstanding under the 2034 Notes is US$510,000,000.

Key Points: 
  • Following this private placement, the aggregate principal amount outstanding under the 2034 Notes is US$510,000,000.
  • For the avoidance of doubt, any holder of 2034 Notes who has previously consented to the Consent Solicitation with respect to the 2034 Notes must validly deliver their consent again in order to receive the Consent Payment (as defined in the Supplemental Consent Solicitation Statement).
  • The Corporation reserves the absolute right, subject to applicable laws, to further amend, waive or modify the terms of the Consent Solicitations in any manner.
  • For additional information regarding these risks and uncertainties, and the assumptions underlying the forward-looking statements, please refer to the Supplemental Consent Solicitation Statement.\n'

Petros Pharmaceuticals to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021

Retrieved on: 
Friday, May 14, 2021
Medical specialties, Penis disorders, Human sexuality, Sexual health, Psychiatric diagnosis, Clinical medicine, Men's Health, Andrology, Peyronie's disease, Erectile dysfunction, Endothelium

b"NEW YORK, May 14, 2021 /PRNewswire/ --Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.\nPresident and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 9:30am ET on May 18, 2021.\nInvestors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.\nPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.\n"

Key Points: 
  • b"NEW YORK, May 14, 2021 /PRNewswire/ --Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.\nPresident and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 9:30am ET on May 18, 2021.\nInvestors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.\nPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.\n"

Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference

Retrieved on: 
Thursday, May 13, 2021
Medical devices, Health, Other Health, Other Science, Science, Biotechnology, Human sexuality, Academic disciplines, Sexology, Intel X99, Pulse, Erotic electrostimulation

b'Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation\xe2\x84\xa2 (NPS\xe2\x84\xa2) technology, today announced the podium presentation of four clinical studies of NPS technology at the American Society for Laser Medicine and Surgery (ASLMS) Virtual Annual Meeting taking place on May 15-16, 2021.

Key Points: 
  • b'Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation\xe2\x84\xa2 (NPS\xe2\x84\xa2) technology, today announced the podium presentation of four clinical studies of NPS technology at the American Society for Laser Medicine and Surgery (ASLMS) Virtual Annual Meeting taking place on May 15-16, 2021.
  • Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy.
  • The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes.
  • These statements are not historical facts but rather are based on Pulse Biosciences\xe2\x80\x99 current expectations, estimates, and projections regarding Pulse Biosciences\xe2\x80\x99 business, operations and other similar or related factors.

Guided by Glow Introduces New Audio Erotica Experience For Sexual Meditation

Retrieved on: 
Wednesday, May 12, 2021
Mind–body interventions, Spirituality, Meditation, Human behavior, Articles, Human sexuality, Sexual acts, Mindfulness, Orgasm, Effects of meditation, Buddhist meditation

b'NEW YORK, May 12, 2021 /PRNewswire/ -- Guided by Glow, a new sexual wellness company focused on sophisticated auditory sensory stimulation, today announced the launch of its erotic app for Android and Apple devices, or at https://guidedbyglow.com .

Key Points: 
  • b'NEW YORK, May 12, 2021 /PRNewswire/ -- Guided by Glow, a new sexual wellness company focused on sophisticated auditory sensory stimulation, today announced the launch of its erotic app for Android and Apple devices, or at https://guidedbyglow.com .
  • The app has a range of episodes for women tailored to their sexual preferences and is available as an all-access subscription for $47.99 per year or $8.99 per month for those aged 18+.\nGuided by Glow seeks to elevate sexual wellness through guided meditation soundscapes designed to ignite the imagination.
  • "My vision was to combine the natural positivity and glow induced by an orgasm with the mental and physical satisfaction of meditation for a more elevated aural experience -- something we haven\'t really seen in this space before.
  • "\nGuided by Glow promises to engage neural pathways and deepen the connection to the body by emphasizing sensory mindfulness and breathing.

Black Lesbian Erotica Author Debuts Little Book of Quickies

Retrieved on: 
Wednesday, May 12, 2021
Personal life, Human sexuality, Lesbian erotica, Lesbian, Erotic literature, Eroticism, Articles

b'HOUSTON, May 12, 2021 /PRNewswire/ --It has been a while since ablack and lesbian erotica author has dared shake up the erotic literature landscape.

Key Points: 
  • b'HOUSTON, May 12, 2021 /PRNewswire/ --It has been a while since ablack and lesbian erotica author has dared shake up the erotic literature landscape.
  • This is particularly true for lesbians from the black community, in a society where being gay is still very much a taboo.
  • After doing her research into erotic literature, Ro Desire was dismayed to learn that black lesbian writers are still today highly underrepresented.
  • Growing up in Houston, Ro Desire is no stranger to the two-fold social prejudice when one is a lesbian of color.

Worldwide Electric Bed Industry to 2028 - Featuring Medline Industries, Hill-Rom Services and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, May 7, 2021
Medical devices, Health, Bed, Human sexuality, Mattresses, Sleep

b'The "Electric Bed Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By End-Use; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global electric bed market size is expected to reach USD 4.12 billion by 2028 according to a new study.

Key Points: 
  • b'The "Electric Bed Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By End-Use; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global electric bed market size is expected to reach USD 4.12 billion by 2028 according to a new study.
  • The report gives a detailed insight into current market dynamics and provides analysis on future market growth.\nThe electric bed allows the patient to adjust both upper and lower body positions with a self-adjustable height feature.
  • They help in a variety of medical complaints and rapidly increase patient\'s comfort.
  • The operator can control the operation of the product with voice commands, and buttons.\n'

Petros Pharmaceuticals to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 13, 2021

Retrieved on: 
Friday, May 7, 2021
Medical specialties, Penis disorders, Human sexuality, Sexual health, Psychiatric diagnosis, Clinical medicine, Men's Health, Andrology, Peyronie's disease, Erectile dysfunction, Endothelium

b"NEW YORK, May 7, 2021 /PRNewswire/ --Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Benzinga Global Small Cap Conference on May 13, 2021.\nPresident and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 10:50am ET on May 13, 2021.\nInvestors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.\nInvestors can register for the conference here:\nPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.\n"

Key Points: 
  • b"NEW YORK, May 7, 2021 /PRNewswire/ --Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Benzinga Global Small Cap Conference on May 13, 2021.\nPresident and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 10:50am ET on May 13, 2021.\nInvestors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.\nInvestors can register for the conference here:\nPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.\n"

Oi S.A. - In Judicial Reorganization Announces Expiration Of, And Receipt Of Required Consents In Connection With, The Consent Solicitation For 10.000%/12.000% Senior PIK Toggle Notes Due 2025

Retrieved on: 
Thursday, May 6, 2021
Articles, Sexual ethics, Ethics, Autonomy, Crime, Medical ethics, Human sexuality, Rape, Sexual consent, Solicitation, Consent

The Consent Solicitation was made solely by means of the Consent Solicitation Statement.

Key Points: 
  • The Consent Solicitation was made solely by means of the Consent Solicitation Statement.
  • As of the Expiration Date, the Company received consents from the holders of a majority in aggregate principal amount of the Notes.
  • THE CONSENT SOLICITATION IS ONLY BEING MADE PURSUANT TO THE CONSENT SOLICITATION STATEMENT.
  • THE CONSENT SOLICITATION IS SUBJECT TO CERTAIN TERMS AND CONDITIONS, AS SET FORTH AND DETAILED IN THE CONSENT SOLICITATION STATEMENT.\nImportant Notice Regarding Forward-Looking Statements:\nThis press release contains certain forward-looking statements.

Former Children's Home of Poughkeepsie Residents Allege Child Sexual Abuse in Six Lawsuits Filed by Greenstein & Milbauer, LLP

Retrieved on: 
Wednesday, May 5, 2021
Child sexual abuse, Human sexuality, Sexual abuse, Articles, Violence against children, Human behavior, Violence

The lawsuits accuse staff and, in one case, an older resident of child sexual abuse.

Key Points: 
  • The lawsuits accuse staff and, in one case, an older resident of child sexual abuse.
  • New York residents who were sexually abused as children now have until August 14, 2021, to pursue child sexual abuse claims.
  • The child sexual abuse began with kissing, fondling, oral sex, and eventually vaginal sexual contact.\nThe New York Child Sexual Abuse Lawyers at Greenstein & Milbauer, LLP are offering free consultations.
  • Call 1-800-VICTIM2 (1-800-842-8462).\nIf you were sexually abused as a child, the New York Child Sexual Abuse Lawyers at Greenstein & Milbauer LLP help.Schedule a free, confidential consultation by calling 1-800-VICTIM2 (1-800-842-8462).\n'